Trials / Unknown
UnknownNCT02414516
A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors
A Phase 1a Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Oncolys BioPharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This Phase 1a, single center, open-label, repeat dose study will evaluate the safety, efficacy, and Pharmacokinetics of ascending doses of OBP-801 in patients with advanced solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OBP-801 | OBP-801 will be administered IV |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2019-06-01
- Completion
- 2019-08-01
- First posted
- 2015-04-10
- Last updated
- 2019-03-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02414516. Inclusion in this directory is not an endorsement.